Caremark RX is a pharmacy benefit management firm that's been rangebound since about August of last year. My guess is that a longer term breakout seems possible because of its present P/E of only 5.49 and recent analyst coverage starting CMX at a "buy." The "aging population" demographic also makes... Sign in to see full entry.